Showing results (1811-1820 of 2,503) with videos related to
Sort By:
Pageof 251
The American Journal of Cardiology|November 1, 1994
Risk factors for exercise-induced silent myocardial ischemia in healthy volunteersL I Katzel, K D Sorkin, E Colman, et al.The Journal of Biological Chemistry|August 9, 2003
Nitric oxide protects cardiac sarcolemmal membrane enzyme function and ion active transport against ischemia-induced inactivationKai Y Xu, Shanmuga P Kuppusamy, Jing Q Wang, et al.Pain Medicine (Malden, Mass.)|August 9, 2019
Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi StudyJoanna L Starrels, Sarah R Young, Soraya S Azari, et al.Journal for Immunotherapy of Cancer|May 31, 2019
Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?Anne Zaremba, Eleftheria Chorti, Finja Jockenhöfer, et al.European Journal of Gastroenterology & Hepatology|April 6, 2000
A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern FranceS Bresson-Hadni, D A Vuitton, B Bartholomot, et al.Journal of Thrombosis and Thrombolysis|April 20, 2011
Dose selection for a direct and selective factor IXa inhibitor and its complementary reversal agent: translating pharmacokinetic and pharmacodynamic properties of the REG1 system to clinical trial designT J Povsic, M G Cohen, M Y Chan, et al.European Heart Journal|September 30, 2015
Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO studyEmil Hagström, Stefan K James, Maria Bertilsson, et al.Physical Review Letters|May 21, 2010
Viscous Rayleigh-Taylor instability experiments at high pressure and strain rateHye-Sook Park, K T Lorenz, R M Cavallo, et al.Lancet (London, England)|August 31, 2010
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trialLars Wallentin, Stefan James, Robert F Storey, et al.International Journal of Toxicology|May 8, 2010
Final report of the safety assessment of allantoin and its related complexesLillian C Becker, Wilma F Bergfeld, Donald V Belsito, et al.Pageof 251